COQ5 Protein
Introduction Coq5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview COQ5 Protein (Coenzyme Q Biosynthesis Factor COQ5) is a mitochondrial methyltransferase that catalyzes the C5-methylation step in coenzyme Q (CoQ) biosynthesis. COQ5 converts 5-demethoxy-ubiquinone (DMQ) to intermediate forms that are subsequently hydroxylated to produce ubiquinone (CoQ10), the essential electron carrier in the mitochondrial respiratory chain. [@stefely2016]
<div class="infobox infobox-protein"> [@desbats2015] <table> [@hargreaves2014] <tr><th>Protein Name</th><td>COQ5</td></tr> [@liu2020] <tr><th>Gene</th><td>[COQ5](/proteins/coq5-protein)</td></tr> <tr><th>UniProt ID</th><td>Q9NXK5</td></tr> <tr><th>Molecular Weight</th><td>~38 kDa</td></tr> <tr><th>Subcellular Localization</th><td>Inner mitochondrial membrane</td></tr> <tr><th>Cofactors</th><td>S-adenosylmethionine (SAM)</td></tr> <tr><th>Protein Family</th><td>Radical SAM methyltransferases</td></tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td> </tr> </table> </div>
Structure COQ5 is a S-adenosylmethionine-dependent methyltransferase with:
...
COQ5 Protein
Introduction Coq5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview COQ5 Protein (Coenzyme Q Biosynthesis Factor COQ5) is a mitochondrial methyltransferase that catalyzes the C5-methylation step in coenzyme Q (CoQ) biosynthesis. COQ5 converts 5-demethoxy-ubiquinone (DMQ) to intermediate forms that are subsequently hydroxylated to produce ubiquinone (CoQ10), the essential electron carrier in the mitochondrial respiratory chain. [@stefely2016]
<div class="infobox infobox-protein"> [@desbats2015] <table> [@hargreaves2014] <tr><th>Protein Name</th><td>COQ5</td></tr> [@liu2020] <tr><th>Gene</th><td>[COQ5](/proteins/coq5-protein)</td></tr> <tr><th>UniProt ID</th><td>Q9NXK5</td></tr> <tr><th>Molecular Weight</th><td>~38 kDa</td></tr> <tr><th>Subcellular Localization</th><td>Inner mitochondrial membrane</td></tr> <tr><th>Cofactors</th><td>S-adenosylmethionine (SAM)</td></tr> <tr><th>Protein Family</th><td>Radical SAM methyltransferases</td></tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td> </tr> </table> </div>
Structure COQ5 is a S-adenosylmethionine-dependent methyltransferase with:
N-terminal mitochondrial targeting sequence - 20-30 amino acid leader peptide
Catalytic methyltransferase domain - Contains the active site for C5-methylation
SAM-binding pocket - Recognizes and binds the methyl donor
Substrate-binding channel - Accommodates the hydrophobic CoQ intermediateThe protein forms a homodimer in solution, which is required for full enzymatic activity.
Normal Function
CoQ Biosynthesis COQ5 catalyzes the C5-methylation step in the CoQ biosynthetic pathway:
Substrate : 5-demethoxy-ubiquinone (DMQ)
Product : 5-methoxy-ubiquinone (intermediate)
Cofactor : S-adenosylmethionine (SAM) provides the methyl groupThis methylation step is essential because:
The methyl group is required for proper CoQ function
It prepares the molecule for subsequent hydroxylation reactions
The final product (CoQ10) requires the methyl group for electron transfer
Mitochondrial Function
Electron Transport Chain - CoQ10 transfers electrons from Complex I/II to Complex III
ATP Production - Supports oxidative phosphorylation
Antioxidant Defense - CoQ10 neutralizes [ROS](/entities/reactive-oxygen-species) in mitochondrial membranes
Membrane Fluidity - Regulates mitochondrial membrane properties
Brain Region Distribution COQ5 expression in the brain:
Cerebral [Cortex](/brain-regions/cortex) - Neuronal expression, highest in layer 5 pyramidal [neurons](/entities/neurons)
[Hippocampus](/brain-regions/hippocampus) - CA1 neurons and dentate gyrus granule cells
Cerebellum - Purkinje cells and granule cells
Substantia Nigra - Dopaminergic neurons
Brainstem - Motor and sensory nuclei
Molecular Mechanisms
Catalytic Mechanism
SAM binds to the active site of COQ5
DMQ substrate enters the substrate-binding pocket
Methyl transfer occurs via SN2-like mechanism
S-adenosylhomocysteine (SAH) is released
Methylated product exits for further processing
Protein Complex COQ5 is part of the CoQ biosynthesis complex:
COQ4 - Scaffold protein organizing the complex
COQ6 - Hydroxylates the methylated product
COQ7 - Additional hydroxylations
COQ8A/COQ8B - Kinases regulating the pathway
COQ9 - Lipid-binding protein stabilizing the complex
Role in Disease
Primary CoQ10 Deficiency COQ5 mutations lead to primary CoQ10 deficiency:
Encephalomyopathy - Muscle weakness and neurological impairment
Ataxia - Cerebellar ataxia with coordination problems
Myopathy - Muscle disease with exercise intolerance
Hearing loss - Sensorineural deafness
Nephropathy - Kidney disease in some cases
Neurodegenerative Disease Connections
Parkinson's Disease
Mitochondrial Complex I deficiency in PD substantia nigra
CoQ10 levels reduced in PD patient brains
Genetic variants in CoQ biosynthesis genes may influence PD risk
COQ5 expression altered in PD models
Alzheimer's Disease
Mitochondrial dysfunction is an early event in AD
CoQ10 levels decline with aging and AD progression
Oxidative stress increased in AD brain
CoQ10 supplementation tested in clinical trials
Amyotrophic Lateral Sclerosis
Energy metabolism impaired in ALS motor neurons
Mitochondrial dysfunction in ALS models and patients
CoQ10 has been investigated in ALS trials
Multiple System Atrophy
CoQ10 deficiency reported in some MSA patients
Mitochondrial defects in MSA brain
Candidate for CoQ10 therapy
Therapeutic Targeting
Current Therapeutic Strategies | Agent | Mechanism | Clinical Status | |-------|-----------|-----------------| | Ubiquinol (CoQ10) | Electron carrier, antioxidant | Widely available supplement | | Idebenone | Synthetic CoQ10 analog | Approved for Friedreich's ataxia | | MitoQ | Mitochondria-targeted antioxidant | Research phase | | CoQ10 nanoemulsions | Improved bioavailability | Clinical trials |
Challenges in Therapy
Poor Oral Bioavailability - CoQ10 has limited absorption
[Blood-Brain Barrier](/entities/blood-brain-barrier) - Difficult to achieve CNS concentrations
Mitochondrial Targeting - Need to reach the inner membrane
Optimal Dosing - Unclear therapeutic window
Future Directions
Gene therapy to enhance CoQ biosynthesis
Small molecule CoQ pathway activators
Mitochondria-targeted antioxidants (MitoQ, SkQ1)
Combination approaches with other mitochondrial protectants
Animal Models
Coq5 knockout mice - Embryonic lethal, demonstrates essential function
Yeast coq5 mutants - Require CoQ supplementation for growth
Zebrafish models - Show developmental defects
See Also
[COQ5 Gene](/proteins/coq5-protein)
[Coenzyme Q10](/therapeutics/coenzyme-q10-neurodegeneration)
[Mitochondrial Dysfunction Pathway](/mechanisms/mitochondrial-dysfunction-pathway)
[COQ6 Protein](/proteins/coq6-protein)
[COQ7 Protein](/proteins/coq7-protein)
[COQ9 Protein](/proteins/coq9-protein)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Alzheimer's Disease](/diseases/alzheimers-disease)
External Links
[UniProt: Q9NXK5](https://www.uniprot.org/uniprot/Q9NXK5)
[GeneCards: COQ5](https://www.genecards.org/cgi-bin/carddisp.pl?gene=COQ5)
Background The study of Coq5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Wang Y, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/26225998/)
[Stefely JA, et al, (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27605618/)
[Desbats MA, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25999232/)
[Unknown, Hargreaves IP (2014). Coenzyme Q10 as a therapy for mitochondrial disease (2014)](https://pubmed.ncbi.nlm.nih.gov/24815075/)
[Liu J, et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32474261/)
Show full description